contractual research - health.belgium.be · a mixed virtual pot/non-competitive mechanism is often...
TRANSCRIPT
Call for submission of new
RT, RF & RI project proposals
2020 call
Deadline for submission of proposals: April 18th, 2019 at 12 noon sharp
Contractual Research
relating to food safety and animal and plant health policy
1
TABLE OF CONTENTS
Page
1. Introduction 3
1.1 General context 3
1.2 Thematic call (RT projects) 3
1.3 Open call (RF projects) 3
1.4 International call (RI projects): plant health – Euphresco 4
1.5 Using the food consumption survey data 6
1.6 Submitting proposals
2. Thematic call (RT projects) 8
2.1 Step 1 8
2.1.1 Writing the RT pre-proposal 8
2.1.2 Evaluation of the RT pre-proposal 8
2.2 Step 2
2.2.1 Writing the RT full proposal 10
2.2.2 Evaluation of the RT full proposal 10
3. Open call (RF projects) 12
3.1 Step 1 12
3.1.1 Writing the RF pre-proposals 12
3.1.2 Evaluation of the RF pre-proposals 12
3.2 Step 2 18
3.2.1 Writing of the RF full proposal 18
3.2.2 Evaluation of the RF full proposal 18
4. International call (RI projects): plant health – Euphresco 19
4.1 Step 1 19
4.1.1 Writing the RI Expressions of Interest 19
4.1.2 Evaluation of the RI Expressions of Interest 19
4.2 Step 2 20
5. Additional information 20
2
Annexes 21
Annex 1 – Research topics (RT projects) 22
Annex 2 – Template RT pre-proposal (RT project 1st step) 35
Annex 3 – Template RT full proposal (RT project 2nd step) 39
Annex 4 – Template RF pre-proposal (RF project 1st step) 47
Annex 5 – Template RF full proposal (RF project 2nd step) 51
Annex 6 – Important information about the budget 59
Annex 7 – Table to be used for the budgetary overview 64
Annex 8 – Template to be used for the detailed budgetary information 65
Annex 9 – Research topics (RI projects): plant health - Euphresco 67
Annex 10 – Template Expression of Interest (RI project 1st step) 73
3
1. INTRODUCTION
1.1 General context
The Federal Public Service Health, Food Chain Safety and Environment (FPS Health) allocates
grants for scientific research that supports its food safety and plant and animal health policy.
All the Belgian research institutions may apply in response to this call for proposals.
The Contractual Research unit is in charge of organising the call for proposals and overseeing
the selection procedure.
Research grants may be allocated for RT (Targeted Research), RF (“Free” Research – open
call) and RI (International Research) projects.
Due to budgetary restrictions, it is possible that in 2020 only a small number of projects may
be funded.
1.2 Thematic call (RT projects)
The thematic call is a call for proposals based on targeted research topics. Because of budgetary
restrictions, the thematic call has been changed compared to the preceding RT calls.
A distinction is made between priority topics on the one hand, and additional topics on the
other hand. The FPS Health will prioritise the funding of research projects submitted in
response to the priority topics.
RT research projects submitted in response to the additional topics may be funded in case the
budgetary situation allows it. Moreover, they will have to compete with the RF projects
submitted in response to the open call (cf. 1.3 Open call).
The evaluation and selection of the proposals are performed in two steps. In the first step, an
RT pre-proposal is submitted. If selected for the second step, this is followed by the submission
of a detailed full proposal.
During the first step the RT pre-proposals will be selected based on the evaluation of their
relevance with respect to the topic, the applicability of their results for the Government and
their scientific quality.
For the selected pre-proposals a fully elaborated and detailed full proposal needs to be
submitted in the second step. Then it will be evaluated in-depth for its relevance and scientific
quality.
During the 2018 call the general success rate for the RT projects was 66,7 %. The average
success rate per topic was 79,2 %.
1.3 Open call (RF projects)
In the framework of the open call, RF research proposals in support of policy relating to food
safety and animal and plant health are submitted. The subject of the RF proposals is determined
by the researchers.
In the first step, the research proposals are submitted as RF pre-proposals, which will be used
in the pre-selection procedure for evaluation of the relevance of the proposed research for food
safety and plant and animal health policy and evaluation of its scientific quality.
The selected applicants will be asked to submit a fully elaborated and detailed project proposal
4
in the second step. The scientific quality of the full proposal is then evaluated in-depth.
During the 2018 call the RF applicants had a success rate of 17,5 %. Due to budgetary
restrictions, it is possible that for the 2020 call only a small number of RF projects may be
funded. Moreover, the projects of the open call will have to compete with RT research projects
submitted in response to the additional topics (cf. 1.2 Thematic call and annex 1).
Consequently, the success rate in the RF call may be lower than that of the preceding calls.
1.4 International call (RI projects): plant health - Euphresco
The international call for proposals relates to targeted international research topics in the field
of plant health. These topics were selected out of a list drafted by the Euphresco network.
1.4.1 Introduction
Euphresco is an international network of organisations in the phytosanitary area. It currently
comprises ca. 70 organisations from more than 50 countries. The network office is hosted by
the European and Mediterranean Plant Protection Organization (EPPO, Paris). The network
aims to enhance coordination and collaboration in phytosanitary research funding.
More information about the network can be found on the website www.euphresco.net.
Every year Euphresco organizes a call to fund transnational research projects. Euphresco
transnational research funding is considered most appropriate for applied research in relatively
small projects of short to medium duration (1–3 years), i.e. enabling rapid and customized
answers to needs related to quarantine plant pests.
The funding mechanism and the project budget will be determined by the funders involved.
Within the Euphresco network, three main funding mechanisms are applied: real pot, virtual
pot and non-competitive mechanism.
The FPS Health can, within its regulatory framework, only participate via the virtual pot
mechanism, meaning that it can only fund its own, national research institutes, and only through
projects selected via a competitive procedure.
As many Euphresco-partners are able and prefer to work via the non-competitive mechanism,
a mixed virtual pot/non-competitive mechanism is often set up, as is the case here : the
Contractual Research unit of the FPS Health launches a virtual pot call for Belgian research
institutes. The selected Belgian consortium then joins the research consortium built by the
non-competitive partners.
5
1.4.2 Procedure
The FPS Health has selected five priority topics out of the list of 22 research priorities identified
by the Euphresco network (see annex 9).
The project proposals will be selected in a two-stage process.
In the first step, there is a call for the submission of Expressions of Interest (see annex 10) for
the five topics.
In a second step, invitations for submission of full proposals will be sent out for those
Expressions of Interest that are judged to be eligible.
The fully elaborated and detailed full proposals must describe the specific tasks of the Belgian
research providers as part of the transnational research project.
It will be evaluated for its relevance and scientific quality by an international Expert panel.
This second stage is managed by the Euphresco secretariat (Mr Baldissera Giovani). Based
on the results of the evaluation and after consultation of the Evaluation Committee of the
Contractual Research unit, the competent Minister will decide on the funding of the selected
proposals, taking into account the available budget.
Attention: this call is launched early in order to align the timing of the national call as closely
as possible with the overarching Euphresco timing. This has the following consequences.
• A number of the selected topics could drop out in a later stage, for instance because of
insufficient interest from the other transnational partners. Not later than Friday,
March 22nd, 2019 the Contractual Research unit will publish a first update of the topics
on its website. A final list will only be available mid-November 2019. This means that
even after the start of the second stage, topics may still be dropping out.
• Some topic descriptions, describing the transnational research ideas, are only concisely
developed. Fully elaborated topic descriptions will be available early July 2019, and
will be communicated to the coordinators of the proposals selected for the second stage.
The FPS Health will allocate a maximum total budget of € 200,000 for the current RI call.
This means that it’s possible that not all proposals receiving a positive evaluation will be
funded.
The requested grant must correspond with the real cost in relation to the duration, the nature,
the required equipment and expertise of the research needed to achieve the objectives pursued.
6
1.5 Using the food consumption survey data
Regarding project proposals that require using the data of the Belgian national food
consumption survey 2014 (FCS 2014), the options are the following.
1. Either you obtain access to the database containing the gross individual consumption
data, for use within a single specific project, by paying a €5,000 fee. The
pseudonymised dataset is put at your disposal after following the procedure of the
Information Security Committee (Chamber of Social Security and Health), as explained
on the FCS website. As an alternative, for risk exposure assessments, an anonymised
dataset can be put at your disposal without the procedure of the Information Security
Committee. Such a dataset comprises, besides food and food supplement consumption
data (i. e. 24-hour recalls linked with the food composition tables and food frequency
questionnaires), only the following information: age, gender, province, education level,
pregnancy/breast feeding, height, weight and waist circumference. In this case, the
researchers themselves need to provide the software, the expertise and the staff to
perform the calculations. For any questions on this subject, please contact Dr Karin De
Ridder ([email protected]) or Dr Jean Tafforeau
2. or you commission Sciensano to perform the intake estimates. If you wish to do so,
please contact Dr Mirjana Andjelkovic of Sciensano's Chemical and physical health
risks service ([email protected]) prior to submitting the detailed
project proposal.
To give you an idea of the available data, the FPS Health is putting at your disposal the
frequency tables set up by Sciensano, on the Contract Research website, free of charge. These
tables show the consumption frequency of foodstuffs, grouped in several levels according to
the food classification system FOODEX. More specifically it shows how many people have
consumed a particular foodstuff or group of foodstuffs during the survey. Different variables
are shown:
• intake on the 1st day of the 24-hour recall (N_d1)
• intake on the 2nd day (N_d2)
• intake on 1 day only (N1day)
• intake on both days of the survey (N2days)
• fulfilment of criterion “At least 10 people consumed this foodstuff both on the 1st and
2nd day” (SPADE=1) or “Less than 10 people consumed this foodstuff both on the 1st
and 2nd day” (SPADE=0).
These frequency tables can be used, for instance:
• for setting priorities;
• for defining a sampling scheme;
• for assessing the feasibility of intake calculations. To calculate the “usual intake” with
the SPADE software, the number of people consuming the foodstuff both on the 1st and
2nd day must be at least equal to 10 (criterion “SPADE=1”).
7
1.6 Submitting the proposals
Step 1
the RT and RF pre-proposals and the RI Expressions of Interest must be submitted no later
than
THURSDAY APRIL 18th, 2019 at 12 noon sharp.
Only an electronic version must be provided.
This is to be sent to: [email protected]
Project proposals submitted after this deadline will be considered ineligible.
Step 2
the RT, RF and RI full proposals must be submitted no later than
FRIDAY SEPTEMBER 27th, 2019 at 12 noon sharp.
Only an electronic version must be provided.
RT and RF full proposals are to be sent to: [email protected]
RI full proposals are to be sent to: [email protected]
Project proposals submitted after this deadline will be considered ineligible.
8
2. THEMATIC CALL (RT PROJECTS)
The RT project proposals are evaluated in two steps:
• step 1: submission of an RT pre-proposal
• step 2: submission of an RT full proposal.
The maximum duration of an RT project is mentioned in the topic description.
For the 2020 call a distinction is made between priority topics on the one hand, and additional
topics on the other hand : see also 2.1.2.2.
2.1 STEP 1
2.1.1 Writing the RT pre-proposal
All the required templates are available online on the website of the Contractual Research unit
(www.health.belgium.be/contractualresearch), under “Submitting a project proposal”.
• The research topics of the thematic call are listed in annex 1. The RT pre-proposals
must be drafted based on the listed information and the requirements set out in the topic
descriptions.
• Annex 2 provides the template to be used for the RT pre-proposals.
• Annex 6 contains important information for estimating the budget.
For your information: Annexes 7 and 8 must only be submitted in the second step.
The project pre-proposals are to be submitted digitally only (Word and pdf).
2.1.2 Evaluation of the RT pre-proposals
2.1.2.1 Eligibility of the RT pre-proposals
The eligibility of the RT pre-proposals will be evaluated based on:
1. their timely submission: by Thursday 18th of April, 2019, 12 NOON SHARP. The
date and the time of the e-mail shall constitute proof.
2. their form
• the proposals must be submitted in accordance with the guidelines set out in annex
2
• the indicated limits must be respected and the font of the text (Times New Roman,
font size 12) may not be modified
• the application shall consist of no more than 6 pages, excluding the title page and
the identification of the promoters
• the application shall be drawn up either in one or a combination of the national
languages, or else entirely in English.
3. their accordance with a topic
Only RT pre-proposals that correspond with one of the the topics listed in annex 1 and
which take into account the listed research questions and requirements shall be eligible
4. the absence of an overlap with existing or ongoing research
5. composition of the consortium
Only Belgian research institutions may participate in the consortium.
Please note: if you do not comply with these conditions, your pre-proposal
will be considered ineligible.
2.1.2.2 Evaluation of the contents of the RT pre-proposals
9
Only the RT pre-proposals that are deemed eligible will be evaluated according to the criteria
below:
1. the relevance score (out of 30 points) as an indication of the extent to which the pre-
proposal corresponds to a topic and the potential impact of the proposed research.
In particular, the following elements will be evaluated :
• the extent to which the proposal answers the requirements listed in the topic
description
• the value and applicability of the expected results
• the solution-oriented approach of the research
• the added value with regard to ongoing or existing research
• the potential contribution to policy decisions
Only the RT pre-proposals obtaining a relevance score of at least 21/30 will be included
in the scientific evaluation.
2. the scientific score (out of 20 points) as an indication of
• the scientific quality
• the methodology
• the originality
• the feasibility
of the proposed research.
The Evaluation Committee will normally be completing this evaluation by early July 2019.
The pre-proposals will be ranked by topic, based on the overall score out of 50 points. An
additional requirement is that the projects must have obtained a score of at least 13/20 for the
scientific aspect. A priority list of RT pre-proposals will be drafted based on this ranking.
Priority pre-proposals are the proposals at the top of the ranking list and for which the
Evaluation Committee gives a positive recommendation for inclusion in the priority list to the
competent Minister.
As mentioned under 1.2, the FPS Health will prioritise the funding of research projects
submitted in response to the priority topics. RT research projects submitted in response to
additional topics may be funded if the budgetary situation allows it. Moreover, they will need
to compete with the RF proposals in the open call.
During the second stage of the evaluation, priority RT proposals may be evaluated in
competition with other proposals submitted within the same topic. The scientific counsellor
will inform the promoters whether or not their proposal is in competition with (an)other one(s).
In addition, the promoters will be informed about any adjustments needed in the research
programme, the budget or the duration of the project.
10
2.2 Step 2
The coordinators of the priority RT pre-proposals will be asked to submit a detailed and fully
elaborated full proposal for the second step.
2.2.1 Writing the RT full proposals
All the required templates are available online on the website of the Contractual Research unit
(www.health.belgium.be/contractualresearch), under “Submitting a project proposal”.
• Annex 3 is the template to be used for the description of the RT full proposal.
• Annex 6 contains important information regarding the budget estimate.
• Annexes 7 and 8 are the templates to be used for the budget estimate.
The full proposals need to be submitted digitally only (Word and pdf). The budgetary tables
are to be provided in Excel.
2.2.2 Evaluation of the RT full proposals
2.2.2.1 Eligibility of the RT full proposals
The eligibility of the RT full proposals will be evaluated based on:
1. their timely submission: by Friday, 27th of September, 2019, 12 noon sharp. The
date and the time of the e-mail shall constitute proof.
2. their form
• the proposals must be submitted in accordance with the guidelines set out in annex
3
• the indicated limits must be respected and the font of the text (Times New Roman,
font size 12) may not be modified
• the application shall consist of no more than 30 pages, excluding the title page and
the identification of the promoters, but including the budgetary tables
• the application shall be drafted either in one or a combination of the national
languages, or else entirely in English.
Please note: if you do not comply with these conditions, your full
proposal will be considered ineligible.
11
2.2.2.2 Evaluation of the contents of the RT full proposals
An Expert panel will evaluate the full proposals based on the following five criteria:
i. the scientific quality compared with international standards, and the researchers’
level of expertise
ii. the quality of the work plan
iii. the originality of the approach
iv. the feasibility in relation to the proposed objectives, the work plan, the
organisation and the requested budgetary resources
v. the relevance of the project with regard to the objectives described in the call.
When necessary, an oral defence may be permitted during the consensus meeting of the Expert
panel. Nonetheless, it is essential that a clear, complete project proposal be drawn up, and with
the greatest care.
The evaluation of the submitted RT proposals will normally be finalised in the period of
December 2019 – February 2020.
12
3. OPEN CALL (RF PROJECTS)
The RF proposals are evaluated in two steps:
• step 1: submission of an RF pre-proposal
• step 2: submission of an RF full proposal.
The running time allowed for RF projects is minimum 12 months and maximum 48 months.
Due to budgetary restrictions, it is possible that in 2020 only a small number of RF projects
may be funded.
3.1 STEP 1
3.1.1 Writing the RF pre-proposals
All the required templates are available online on the website of the Contractual Research unit
(www.health.belgium.be/contractualresearch), under “Submitting a project proposal”.
• Annex 4 is the template to be used for the RF pre-proposal.
• Annex 6 contains important information for estimating the budget.
For your information: Annexes 7 and 8 must only be submitted in the second step.
The project proposals are to be submitted digitally only (Word and pdf).
3.1.2 Evaluation of the RF pre-proposals
3.1.2.1 Eligibility of the RF pre-proposals
The eligibility of the RF pre-proposals will be evaluated based on administrative criteria and
criteria related to the contents:
Administrative criteria:
1. their timely submission: by Tuesday 18th of April, 2019, 12 noon sharp. The date
and the time of the e-mail shall constitute proof.
2. their form
• the proposals must be submitted in accordance with the guidelines set out in annex
4
• the indicated limits must be respected and the font of the text (Times New Roman,
font size 12) may not be modified
• the application shall consist of no more than 6 pages, excluding the title page and
the identification of the promoters
• the application shall be drawn up either in one or a combination of the national
languages, or else entirely in English.
3. composition of the consortium : only Belgian research institutions may participate in
the consortium.
13
Criteria related to the contents:
1. the absence of an overlap with the topics in the RT call or with existing or ongoing
research
2. the fields of research involved
The research topic must fit within the competences of Contractual Research:
Please note: if you do not comply with these conditions, your pre-proposal
will be considered ineligible.
In general, the research topics should fall within the fields of food safety, animal health
and / or plant health. The research must support or help prepare the policies in these
fields. More specifically this means that the research must provide knowledge which
supports the Government, in particular the FPS Health and the Federal Agency for the
Safety of the Food Chain (FASFC), in one or more of its tasks, including:
• drafting or adjusting legislation, recommendations or opinions
• drafting or adjusting control programs or (auto)control guides
• developing strategies for risk assessment or risk management
• implementing (analysis) methods for checking compliance with regulatory
requirements
• taking measures in crisis situations
• setting priorities or responding to new developments.
The valorisation of new knowledge by the Government can be situated at national,
European and / or international level.
The research topic may not fall within the competence of the regional authorities unless
the aspects that fall within the regional competence are co-funded.
If the project proposal contains work packages or parts of these that are outside the
specific scope of Contractual Research, they must be funded by an external funding
source as well.
The Government is entitled to a general and no-cost use of the results for supporting its
policies. The project proposal must therefore be designed in such a way that all results
can be communicated in detail to the Government (FPS Health and FASFC).
The following table gives a (non-exhaustive) overview of subjects that may and may
not fit within the scope of Contractual Research. Since a clear delineation is not always
possible, experts of the FPS Health and the FASFC assess the substantive admissibility
of each pre-proposal. Some of the examples included arise from the eligibility
evaluation of recent calls.
We recommend that you’d consult the overview of running and concluded projects as
well, which is published on the website of Contractual Research.
If you are unsure of the admissibility of your research idea, you can, before submitting
it, contact the scientific counsellors of the Contractual Research unit (Dr. Dominique
Vandekerchove or Dr. Ria Nouwen, see also "5. Additional information" on page 20).
14
General Eligible Not eligible
Food Safety
Research into the safety
of foodstuffs • throughout the chain (primary production, processing,
storage) up to the time of consumption: chemical and
microbial contaminants, toxins, additives, food
contact materials, nutritional supplements, novel
foods, GMOs, allergens, …
• emerging risks
• antimicrobial resistance
• developing new risk assessment aspects or methods
• developing new methods for sampling and/or analysis
• risk assessments
• intake studies
• research into contamination
• research into sources, routes, reduction and
prevention of contamination
• exploring the impact of possible control measures
• in vitro toxicological examination or animal tests for
contaminants
• investigating the transfer of chemical and microbial
contaminants of animal feed via animals to animal
products
• research in preparation for admission or reassessment
files for additives, novel foods, flavours, food
enzymes, plant protection products, decontamination
products, ….
• research into evidence of health claims
• research into food safety of crops grown by
individuals
• drug research
• human clinical examination
• environmental research
• biodiversity research
• sustainability research, unless there is a clear link
with food safety
• nutritional policy-based research (intake of sugar,
salt, fat, ...) unless there is a clear link with food
safety
• research into nutrient enrichment, unless this affects
food safety policy (e.g. overdose risk)
• research into the impact of exposure to chemical
agents (e.g. plant protection products) by inhalation
or skin contact on the health of employees or
individuals
• routine checks on compliance with existing standards
15
General Eligible Not eligible
Animal Health
Research into diseases,
pathogens and/or
zoonotic agents in
livestock and bees, and
in wildlife if it can act
as a reservoir for
diseases in livestock
Research into
contaminants
• development of new diagnostic methods for animal
diseases
• epidemiological research
• risk factor research
• antimicrobial resistance and other cross-species risks
• developing new risk assessment aspects or methods
• developing new or improved methods for sampling
and/or analysis
• basic research for the identification of vaccine
antigens / proof-of-concept research for the testing of
vaccine antigens and vaccine applications under
specific Belgian animal husbandry conditions
• exploring the impact of possible disease control
measures
• study of zoonotic diseases
• research into chemical and microbial contaminants,
toxins, ... which may adversely affect animal health,
via animal feed or other contamination routes
• (re-)emerging risks
• disease warning and monitoring systems
• mere clinical research in pet animals
• mere zootechnical research
• genetic selection except when it is related to disease
resistance
• nutritional research
• mere animal welfare research (e.g. lameness)
• routine checks on compliance with existing standards
16
General Eligible Not eligible
Plant Health
Research into
organisms that are
harmful to cultivated
and / or wild plants,
including quarantine
organisms, organisms
that are new, unknown
or whose dissemination
is limited and for which
more information is
required in the context
of future regulation or
policy
• determination of the occurrence, distribution (pest
status) and settlement potential
• study of biology
• epidemiological research
• exploring the impact of possible control measures
• developing new risk assessment aspects or methods
• development of new methods for sampling and / or
diagnosis, identification or quantification
• risk assessments
• providing scientific elements for Pest Risk
Assessments (PRA)
• research into quality organisms
• research into invasive species under Regulation
1143/2014
• plant breeding research, except when the breeding
concerns greater (phytosanitary) disease resistance
• research into sustainable agriculture, except when it is
in the field of phytosanitary policy
• environmental research, except when it is in the field
of phytosanitary policy
• biodiversity research, except when it is in the field of
phytosanitary policy
• routine checks on compliance with existing standards
17
3.1.2.2 Evaluation of the contents of the RF pre-proposals
Only the RF pre-proposals that are deemed eligible will be evaluated further, according to the
criteria below:
1. the relevance score (out of 30 points) as an indication of the expediency and the suitability
as research in support of policy and its potential impact. More specifically the following
elements will be evaluated :
a. is the research situated within the federal authorities’ priorities
b. the value and applicability of the expected results
c. the solution-oriented approach of the research
d. the added value with regard to ongoing or existing research
e. the potential contribution to policy decisions
f. the timing in relation to the policy agenda
g. the quantitative importance
h. the gravity of the problem
i. the budgetary impact
j. the social and ethical impact
k. the relevance in relation to sectoral needs
Only the RF pre-proposals obtaining a relevance score of at least 21/30 will be included in
the scientific evaluation.
2. the scientific score (out of 20 points) will be allocated as an indication of
l. the scientific level
m. the methodology
n. the originality
o. the feasibility
of the proposed research.
The Evaluation Committee will normally be completing this evaluation by early July 2019.
A ranking by field of activity will be drafted, based on the overall score out of 50 points. An
additional requirement is that the projects must have obtained a score of at least 13/20 for the
scientific aspect. Moreover, as mentioned under 1.3 the RF projects will need to compete with the
RT projects submitted in response to the additional topics. A priority list and a reserve list of RF
pre-proposals will be drafted based on this ranking.
Priority RF pre-proposals are the pre-proposals at the top of the ranking list and for which the
Evaluation Committee gives a positive recommendation for inclusion in the priority list to the
competent Minister. In addition, the pre-proposals must also fit in with the available research
budget of the FPS Health.
RF pre-proposals on the reserve list have a somewhat lower ranking than the priority pre-
proposals. They also require a positive recommendation from the Evaluation Committee before
they can be included in the reserve list. These projects will only receive a research grant if a budget
becomes available in the RT call or the priority RF group. Nonetheless, the reserve project
proposals shall be submitted to the same evaluation procedure as the priority proposals.
18
3.2 STEP 2
The coordinators of the priority and reserve RF pre-proposals will be asked to submit a detailed
and fully elaborated full proposal for the second step.
3.2.1 Writing the RF full proposals
All the required templates are available online on the website of the Contractual Research unit
(www.health.belgium.be/contractualresearch), under “Submitting a project proposal”.
• Annex 5 is the template to be used for the description of the RF full proposal.
• Annex 6 contains important information regarding the budget estimate.
• Annexes 7 and 8 are the templates to be used for the budget estimate.
The full proposals are to be submitted digitally only (Word and pdf). The budgetary tables are to
be provided in Excel.
3.2.2 Evaluation of the RF full proposals
3.2.2.1 Eligibility of the RF full proposals
The eligibility of the full proposals shall be evaluated based on:
1. their timely submission: by Friday, 27th of September, 2019, 12 noon sharp. The date
and the time of the e-mail shall constitute proof.
2. their form
• the proposals must be submitted in accordance with the guidelines set out in annex 5
• the indicated limits must be respected and the font of the text (Times New Roman, font
size 12) may not be modified
• the application may not exceed 30 pages; the only admissible annex is a bibliography
(not included in the 30 pages)
• the application shall be drawn up either in one or a combination of the national
languages, or else entirely in English.
Please note: if you do not comply with these conditions, your full proposal
will be considered ineligible.
3.2.2.2 Evaluation of the contents of the RF full proposals
An Expert panel will evaluate the full proposals based on the following four criteria:
i. the scientific quality compared with international standards, and the researchers’
level of expertise
ii. the quality of the work plan
iii. the originality of the approach
iv. the feasibility in relation to the proposed objectives, the work plan, the organisation
and the requested budgetary resources.
If necessary, an oral defence may be permitted during the consensus meeting of the Expert panel.
Nonetheless, it is essential that a clear, complete project proposal be drawn up, and with the
greatest care.
The evaluation of the submitted RF full proposals will normally be finalised in the period
December 2019 – February 2020.
19
4. INTERNATIONAL CALL (RI-PROJECTS):
plant health – Euphresco
The RI proposals are evaluated in two steps:
• step 1: submission of an RI Expression of Interest
• step 2: submission of an RI full proposal
4.1 STEP 1
4.1.1 Writing the RI Expressions of Interest
All the required templates are available online on the website of the Contractual Research unit
(www.health.belgium.be/contractualresearch, under “Submitting a project proposal”.
• Annex 6 contains important information for estimating the budget.
• The research topics of the RI-call are listed in annex 9. The RI Expressions of Interest
must be drafted based on the listed information and the requirements set out in the topic
descriptions
• Annex 10 is the template to be used for the RI Expression of Interest.
The “Expressions of Interest” are to be submitted digitally only (Word and pdf).
4.1.2 Evaluation of the RI Expressions of Interest
The “Expressions of Interest” will be evaluated based on their eligibility only.
The eligibility of the RI Expressions of Interest will be evaluated based on:
1. their timely submission: by Thursday, 18th of April, 2019, 12 noon sharp. The date and
the time of the e-mail shall constitute proof.
2. their form
• the proposals must be submitted in accordance with the guidelines set out in annex 10
• the indicated limits must be respected and the font of the text (Times New Roman, font
size 12) may not be modified
• the application shall consist of no more than 4 pages, excluding the title page and the
identification of the promoters
• the application shall be drawn up in English.
3. their accordance with a topic
Only RI proposals that correspond with one of the topics listed in annex 9 shall be eligible.
4. the absence of an overlap with existing or ongoing research.
5. the composition of the consortium
Only Belgian research institutions may participate in the consortium.
Please note: if you do not comply with these conditions, your Expression of
Interest will be considered ineligible.
20
If you are unsure of the admissibility of your research idea, you can, before submitting it, contact
the competent scientific counsellor of the Contractual Research unit (Dr. Ria Nouwen, see also
"5. Additional information" below).
4.2 STEP 2
The applicants of the eligible RI Expressions of Interest will be asked to submit a detailed and
fully elaborated full proposal for the second step.
This step will be managed by the Euphresco-secretariat coordinator, i.e. by Mr Baldissera Giovani.
The applicants will receive the guidelines and templates by mid-July 2019.
The full proposals must be submitted no later than Friday, September 27th, 2019, 12 noon sharp.
The evaluation of the submitted RI full proposals is to be finalised no later than mid-November
2019.
After consultation of the Evaluation Committee, the competent Minister will decide on the funding
of the selected projects.
5. ADDITIONAL INFORMATION You can contact the scientific counsellors of the Contractual Research unit for additional
information:
Dr. Dominique VANDEKERCHOVE
(Tel.: 02/524.90.91 – [email protected]) or
Dr. Ria NOUWEN
(Tel.: 02/524.90.92 – [email protected])
21
ANNEXES
22
Annex 1
Research topics (RT projects)
PRIORITY TOPICS Maximum
duration
(years)
Maximum
grant
Animal health
1 Evaluation of new vaccines and developpement of appropriate
vaccination schedules for Newcastle disease (NCDVAC)
3 € 300.000
Plant health
2 Phytosanitary status of pests for plants and plant products
(HARMSTAT)
2 € 200.000
Food safety
3 Intake of free glutamate (FREEGLUTAMATE) 2 € 200.000
4 Study on the toxicity of Alternaria toxins (ALTERTOX) 2 € 200.000
ADDITIONAL TOPICS Maximum
duration
(years)
Maximum
grant
Animal health
5 Surveillance indicators for the monitoring of side effects
resulting from reduced antibiotic use in livestock (SEREDAB)
2 € 200.000
Plant health
6 Development of a practical phytosanitary analysis for
Vaccinium berries (BERRYPEST)
2 € 200.000
Food safety
7 Development, on the basis of glyphosate and neonicotinoids as
case-control studies, of a decision support grid to integrate the
issue of alternatives when examining or considering decisions
to withdraw pesticides (DECALPE)
2 € 150.000
23
1. Evaluation of new vaccines and development of appropriate vaccination schedules for
Newcastle disease (NCDVAC)
Context
The recent epidemic of Newcastle disease with a genotype not previously circulating in our region
(i.e. genotype VII i) has shown that in the professional sector as well, despite compulsory
vaccination and prescribed vaccination schedules, protection is insufficient. This may be partly
due to sub-optimal execution of vaccination but, certainly in broilers, incomplete or no active
immunity is induced (due to the short life span of broilers).
In order to get a better view of the situation and to be able to provide more optimal vaccination
schedules, it is necessary to assess the effectiveness of the available and recently developed
vaccines and vaccination schedules.
Research questions
• Assessment of existing vaccination schedules for the protection of backyard poultry,
broilers, laying hens and breeding poultry against Newcastle disease
• Develop and assess new vaccination schedules using existing or newly developed vaccines
to provide optimal protection for backyard poultry, broilers, laying hens and breeding
poultry against Newcastle disease. Priority should be given to new vaccination schedules
for those poultry categories for which existing vaccination schedules do not provide
sufficient protection
• Development of methods to measure the immunity of vaccinated poultry in field
conditions.
Maximum duration : 3 years
Maximum research grant : € 300,000
24
2. Phytosanitary status of pests for plants and plant products (HARMSTAT)
Context
When noticing outbreaks of pests that had not previously been encountered (within the EU or in a
Member State), the Member State concerned must take measures to at least prevent their spread to
other Member States. Based on a risk analysis, further measures (e. g. monitoring) can be taken
against such plant pests.
Under the new plant health legislation, work is being carried out for updating the lists of regulated
organisms according to their spread. Moreover, the lists of registered pests can vary depending on
updated data on the presence of those pests and a recent analysis of their risk. New lists are then
established based on a pest categorisation or a complete risk analysis of the pest, performed
following the initiative of a Member State or, for instance, a request made to the EFSA. In turn,
those bodies are referred to national authorities for providing the specific information needed as
an input for the risk analysis.
For some pests, too little information is available to surely assign their plant health status and there
is no certainty about their presence or absence in Belgium. Performing a survey is the most reliable
way to determine or verify such a status (ISPM 8). Besides, for some of those pests, the
development of a diagnostic method or the acquisition of know-how about it is required.
Under the new plant health legislation, more accent is laid on prevention than previously, which
means that a timely sensitization of scientists, operators as well as the wide public plays a major
role. Research into the presence of specific pests about which a problem has arisen can provide an
important contribution to this.
Research questions
• The research to be carried out will make it possible for the FPS Health to determine the status
of the pests to be studied for plants and plant products in Belgium, while essentially providing
a deeper investigation into their biology, geographic spread, host plants, entry and establisment
potential. A precise methodology is needed, combined with a thorough monitoring plan.
Additional research for finalising diagnosis methods may be included if necessary.
• The list of pests to be examined that is provided below, is mainly based on the EPPO alert list,
completed with pests about which new problems have arisen (as reported chiefly by the
Permanent Plant Health Committee and its working groups). The consortium shall include as
many pests mentioned as possible, with a minimum of six, within the requested budget.
25
EPPO alert list
• Curtobacterium flaccumfaciens pv. poinsettiae
• Meloidogyne ethiopica and Meloidogyne luci (+ possibly other tropical organisms such as
M. enterolobii)
• Meloidogyne graminicola
• Agrilus fleischeri
• Agrilus bilineatus
• Xylotrechus chinensis
• Sirococcus tsugae
Recent outbreaks in the EU:
• Tetranychus mexicanus
• Tomato brown rugose fruit virus
Maximum duration : 2 years
Maximum research grant : € 200,000
26
3. Intake of free glutamate (FREEGLUTAMATE)
Context
In the past, additives of the glutamate group were assigned an ADI 'not specified' by the European
Scientific Committee for Food. Such conclusion is made for substances of a very low safety
concern. Consequently, these additives were listed in Group I and the additives were authorised
in all food except some food categories.
Under the review programme of all additives (Regulation 257/2010), the EFSA published in 2017
a re-evaluation of the glutamates. With this re-evaluation, the situation has changed: there is now
a quantitative ADI (acceptable daily intake) of 30 mg/kg body weight per day for the group
consisting of glutamic acid (E620), monosodium glutamate (E621), monopotassium glutamate
(E622), calcium diglutamate (E623), monoammonium glutamate (E624) and magnesium
diglutamate (E625). In this group of additives, monosodium glutamate (MSG) is the most
frequently used. The ADI is expressed in terms of free glutamic acid. It applies to all people except
infants below 16 weeks of age and hence not only to hypersensitive people. The ADI is derived
from a neurotoxicity study.
At least certain persons are sensitive to the so-called MSG symptom complex involving, among
others, headache and neurological effects.
EFSA has also estimated the exposure and compared it with the ADI. The ADI is exceeded even
for the mean consumer of all population groups. Excess doses are greater with children than with
adults. EFSA estimated that for Belgian children, the exposure was the highest of all children in
the EU.
At the moment of re-evaluation, EFSA was not ready to use the most recent Belgian national food
consumption data.
For a food category such as fine bakery wares, more refined estimates are needed than what EFSA
did; e.g. it is appropriate to assign another glutamate concentration level to savoury biscuits than
to sweet biscuits.
Data on free glutamate in foods for infants and toddlers are very limited. More data are needed.
Concentration data are not only needed to estimate the exposure, but also to provide targeted
knowledge to serve as a basis for the elaboration of risk management options aimed to reduce the
exposure.
Exposure comes from several sources. The use of additives is relevant for the exposure resulting
from foods with umami taste such as meat products, soups, snacks and (salty) biscuits, sauces,
noodles and ready-to-eat foods. Other sources than the use of additives are the use of hydrolysed
proteins such as in yeast extract, the development of free glutamate during fermentation and so on.
There are no data on free glutamate in food in Belgium as far as we are aware.
The analytical data obtained during the project should be sent to EFSA.
27
Research questions
1. Identification/development and validation of an appropriate analysis method for free
glutamate in a large number of food categories
2. Elaboration of a sampling scheme, sampling and analysis of free glutamate (survey
occurrence data) in at least 300 foods pertaining to many kinds of food categories that
potentially contribute to the total exposure of consumers to free glutamate, focussing in the
first place on the refined exposure estimate for children. The survey should include foods
for infants containing hydrolysed proteins.
3. Refined exposure estimate of free glutamate and contribution of different food categories
to the total intake, for several groups of age: children, adolescents, adults, (very) elderly
people. The estimate should be using the new analytical data as well as European analytical
data and the most recent refined Belgian national food consumption data.
4. Specific investigation into the potential exposure of infants and young children (< 3 years),
including consumers of food containing hydrolysed proteins
5. Investigation into factors influencing the concentration of free glutamate (besides the use
of additives) and estimation of their relative importance: estimated contribution to
glutamate intake resulting from additives, from yeast extract, ...
Maximum duration: 2 years
Maximum research grant: € 200,000
28
4. Study on the toxicity of Alternaria toxins (ALTERTOX)
Context
Alternaria toxins are secondary metabolites produced by fungi that contaminate cereals, oil seeds,
fruits and vegetables.
In 2011, the EFSA Expert Group on Chemical Contaminants (CONTAM Panel) assessed the risks
to public health from the presence of Alternaria toxins in food. This risk assessment covered 4 of
the known Alternaria toxins, namely alternariol (AOH), alternariol monomethyl ether (AME),
tenuazonic acid (TeA) and tentoxin (TEN). The data reported at the time were characterized by a
high proportion of left-censored data. The highest concentrations were reported in sunflower seeds
and the contribution to dietary exposure was mainly due to grains and seed products, vegetables
and vegetable products and in particular tomato products, fruits and fruit products, alcoholic
beverages, oil seeds and plant oils.
The CONTAM Panel noted that the available toxicity data were limited. Therefore the Threshold
of Toxicological Concern (TTC) approach was used to assess the level of health concern of these
mycotoxins. The TTC approach has been developed to set priorities in assessing the toxicity of
chemical compounds. If the toxicity threshold is exceeded, specific toxicity studies on the
compound should be carried out to further characterize the risks.
In 2016, the CONTAM Panel estimated the dietary exposure of Alternaria toxins in the European
population.
The foodstuffs contributing to dietary exposure were similar to those described in the 2011
opinion. The main difference was the contribution of tomatoes and tomato products especially for
TeA exposure.
EFSA's chronic exposure estimate shows that the TTC threshold for the toxins AOH, AME and
TeA has been exceeded, which means additional toxicity data on these compounds are needed.
While chronic exposure to the main Alternaria toxins appears to be well described, this is not the
case for toxicity data. The EFSA opinion (2011) reported a lack of toxicological data. From a
toxicokinetic point of view, data on the absorption, distribution and excretion of Alternaria toxins
in animals and humans are missing. No data is available on the metabolism of Alternaria toxins
in animals, except for AOH, AME and ALT. Reproductive and developmental studies are limited.
There are no data demonstrating either toxic effects related to food intake and carcinogenicity or
in vivo genotoxicity of Alternaria toxins.
In the 2011 opinion the CONTAM Panel recommended the need for more toxicity data, and
specifically
- data on toxicokinetics, including metabolic data,
- toxicity data on OAH and AME to assess risks, and
- data on the genotoxicity of Alternaria toxins.
29
Research questions
The objective is to investigate the toxicity of Alternaria toxins and particularly the toxins AOH,
AME and TeA in order to contribute to the establishment of a specific toxicological end-point for
these toxins.
Maximum duration: 2 years
Maximum research grant: € 200,000
30
5. Surveillance indicators for the monitoring of side effects resulting from reduced antibiotic
use in livestock (SEREDAB)
Context
Belgium - and by extension Europe - is making great efforts to drastically reduce antibiotic use in
(intensive) livestock production, hoping to stop the emergence of antibiotic resistance. In this
scheme, the accent is laid on reducing the use of major human critical antibiotics next to a general
decrease of the use.
The first studies on the impact of a reduced antibiotic use do not indicate any negative effects on
animal health or profitability (Rojo-Gimeno et al., 2016). Nevertheless, one should be aware that
antibiotics are and remain important for maintaining the health and welfare of production animals.
Possibly can a more dramatic decrease of antibiotic use really involve negative consequences for
animal health and welfare, and for the economic and technical performance of cattle farming.
In its report on the One-Health AMR country visit, the European Commission recommends
maintaining a surveillance when setting ambitious goals to make sure this does not jeopardize
animal health, animal welfare, the economic feasibility of animal production and the profitability
of farms. One of the actions within the Belgian Federal AMR action plan 2019-2020 is monitoring
the mortality of calves.
To get a better sight of the situation, it is essential to rely on several parameters. A higher mortality
is not necessarily the result of reduced antibiotic use, other factors too can induce an increased
mortality. Moreover, mortality is a very advanced stage of the disease process. Other indicators
can possibly provide a view on earlier disease stages and on the prevalence of endemic diseases
and production diseases.
Besides, one of the reasons why too many antibiotics are used is precisely a poor animal health
and/or welfare and these aspects should be improved first to obtain better results with less
antibiotic use. Surveillance indicators should take both aspects into consideration to avoid the
acceptance of high antibiotic use in certain situations.
Possible indicators:
- mortality
- morbidity percentage
- prevalence of injuries in slaughterhouses
- production facts (daily growth, duration of the fattening phase, milk production, ...)
- acute protein phase (Tothova et al., 2014)
- certain blood values
- etc.
31
Research questions
• Development and validation of surveillance indicators for the monitoring of side effects
resulting from reduced antibiotic use in livestock. Veal calves, pigs, broilers and breeding
poultry are a priority. Inclusion of other cattle types and laying hens is a plus.
• Finalization of a manual for using the selected surveillance indicators.
Maximum duration: 2 years
Maximum research grant: € 200,000
32
6. Development of a practical phytosanitary analysis for Vaccinium berries (BERRYPEST)
Context
The part of fruit crops represents 17% of the total EU agricultural production. The estimated EU
trade in fruit and vegetables amounts to €120 billion, involving 550,000 workers and 1.4 million
producers. Pests destroy 14% of the potential food production, which means an impact of about
€10 billion.
New emerging pests and quarantine pests keep on threatening fruit production with as most recent
example the introduction and rapid spread of Drosophila suzukii in the EU. The search for a
solution to control this problematic pest led to the European research project DROPSA. One part
of this project, coordinated by the EPPO, consisted in searching for historic introductions and other
new threats to EU fruit farming, linked with fruit import. The outcome of the study was the
establishment of alert lists of potential pests possibly introduced with apple, mandarin/orange
fruits, table grapes or Vaccinium berries. The study also laid the basis for a methodology for
analysing the risk of commodities, compared with historic risk analyses that rather focus on
individual pests (https://www.eppo.int/RESOURCES/special_projects/dropsa).
Within the new European plant health legislation under Regulation (EU) 2016/2031, European
work has been carried out in 2017-2018 to establish a list of high risk plants for planting, plant
products and other items. Plants for planting are hereby already considered separately in the
legislation due to their risk. Notably through the DROPSA project analysis, fruit also has been
identified as a pathway, while it is traditionally considered as presenting a lower risk in comparison
with plants for planting.
The cultivation of Vaccinium berries in Belgium is an upcoming crop, going together with an
increasing demand for plants (through importation or own production). In a recent past, too, new
pest infestations have been discovered in Belgium and the EU that were possibly linked with the
import of plant material such as Thekopsora minima. Each new pest goes together with new
problems such as the question of the necessity of a regulation, the origin and extent of the
dissemination, the sensitivity of indigenous species and control options.
Based on the abovementioned situation, Vaccinium is a good candidate for practical testing of the
alert list established in the DROPSA project concerning the pests linked with fruit import as well
as for the determination of the status of that crop in general.
33
Research questions
• Which pests can be identified in Vaccinium that have possibly been imported or are
being imported through the international trade of plant material and consumption
products (fruit)?
o To what extent can pests identified in the EPPO study, be found when importing
fruit or after import?
o Which ones are present (whether or not in a latent state) in imported and/or own
plant material?
• What is the present spectrum of pests in Vaccinium berries production in Belgium?
• What is the status of recent EU introductions (Thekopsora minima, Blueberry scorch
virus, …) and the associated risk in Belgium (possible control options, sensitivity of
indigenous species, …)
• Which preventive measures and control strategies can be proposed based on EPPO-
DROPSA recommendations and the results of this project?
Maximum duration: 2 years
Maximum research grant: € 200,000
34
7. Development, on the basis of glyphosate and neonicotinoids as case-control studies, of a
decision support grid to integrate the issue of alternatives when examining or considering
decisions to withdraw pesticides (DECALPE)
Context
Recent cases of scientific and societal controversies concerning plant protection products suggest
that withdrawals of approvals of substances will be more frequent in the future, in particular for
reasons of health and environment protection, or even as a result of court decisions or choices
made by approval holders. However, these withdrawals must be considered in full knowledge of
the facts, in order to avoid having sectors that do not have alternatives, but also to prevent practices
or alternatives that are harmful to health or the environment from being implemented.
Research questions
• The main objective of this work is to initiate complementary work to the “National
Pesticide Reduction Plans”, in order to create the conditions for developing and
encouraging sustainable alternatives to the use of plant protection products, with priority
given to the most problematic substances of concern.
• This work should be based on two case-control studies leading to the development of a
decision support grid:
o can a ban on glyphosate lead to exposure to other herbicidal substances?
Elaborating a benefit/risk balance in terms of consumer exposure in proportion to
food safety under realistic exit scenarios
o prohibiting neonicotinoids may prove counterproductive in the case of beet
growing for pollinators: elaborating a benefit/risk balance in terms of exposure of
pollinators if the use could not benefit from emergency authorizations. The
risk/benefit analysis should also consider the potential effect of an adapted
herbicide policy on the contamination of food with toxic weeds and the associated
risks to food safety (pyrrolizidine and tropane alkaloids, etc.)
o development of a decision support grid to integrate the issue of alternatives when
examining or considering withdrawal decisions.
Maximum duration: 2 years
Maximum research grant: € 150,000
35
Annex 2
Send this form in digital form (Word and pdf) to:
CONFIDENTIAL
RT PRE-PROPOSAL
(RT PROJECT 1st STEP)
MAX. 6 PAGES (EXCL. TITLE PAGE AND THE IDENTIFICATION OF THE PROMOTERS
1. CONTEXT OF THE PROJECT PROPOSAL
[TITLE OF THE TOPIC]
[ACRONYM OF THE TOPIC]
[Title of the project proposal]
2. IDENTIFICATION OF THE COORDINATOR Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
Will this research be conducted in a consortium (with the partners included in the
budget)? If yes, please list the other promoters here (name, affiliation and e-mail
address)
36
3. REPETITION OF THE ACRONYM OF THE TOPIC AND PROJECT TITLE
4. CONTEXT
4.1 Description of the context of this project proposal, taking into account the topic
description (about 20 lines)
4.2 To which extent are you involved in the general problem on which this project proposal
is based? (about 20 lines)
What is your expertise in this field? Have you already conducted research in this field or are
you currently conducting research? If yes, please list the project title(s), the start and end
dates of your research and identify the institution that provided a grant for the research.
Are you working with other institutions in Belgium and/or abroad? If yes, are you a member
of a network?
4.3 To your knowledge, which other projects were recently conducted or are currently
ongoing or planned on the subject, excluding the projects listed under 4.2? (about 10
lines)
Please list the project title(s), the start and end dates of your research and identify the funding
institutions..
5. RESEARCH QUESTIONS (about 20 lines)
To which research question(s) must the proposed study provide an answer to contribute to a
solution to the problem described in the topic?
6. IMPACT OF THE RESEARCH SUBJECT (about 10 lines)
Can the proposed research provide a solution to the described problem?
What will be the (direct or indirect) applicability of the intended results for the authorities,
in the short, medium or long term?
7. DESCRIPTION OF THE PROJECT PROPOSAL
If necessary, brief references may be included in the text (e.g. Johnson et al., 2012).
7.1 Methodology (about 40 lines)
Describe the methodology you will use for this research. Has this methodology been
previously used, by the applicants, by other Belgian researchers or by foreign researchers?
7.2 Available scientific proof in relation to the proposed research (about 20 lines)
Has other research in relation to the proposed subject already yielded convincing elements
(“proof”) which can be used as a starting point for this project? List this research in order of
importance. In which respect is the current project proposal innovative?
37
7.3 Required data (about 10 lines)
Are there any data and/or preliminary knowledge available, which is required for this study?
If yes, is it available in accessible databases? If no data are available yet, then please explain
how these data can be obtained.
7.4 Risks (about 10 lines)
What are the inherent obstacles and/or risks to the proposed project that may compromise its
chances of success? Which solutions do you propose?
8. USE OF THE RESEARCH RESULTS (about 10 lines)
How do you intend to use the results?
- as an intermediary stage for complementary research activities
- for the development, realisation, or dissemination of a procedure or a service
- for the dissemination of new knowledge through scientific publications
9. BUDGETARY INFORMATION
Please refer to the important information in Annex 6.
For your information: Annexes 7 and 8 must only be submitted in the second step
9.1 Total duration of the proposed project … months
9.2 Total budget for this project proposal € …….
9.3 Requested research grant € …….
The requested grant – 1 figure only – can be equal to the overall budget or to a percentage of
this budget. In the latter case, please state the origin of your external financial contribution.
9.4 In which case: percentage of co-funding …… %
9.5 In which case: origin of the co-funding
38
9.6 Persons included in the budget, their qualification (e.g. PhD, PhD student, engineer,
Ma., pharmacist, lab technician, et al.), affiliation and time spent on the research in
person-months (P-M)
Qualification Name (if known) Affiliation (research
centre)
P-M
NB : have the conditions below been
respected?
If not, your proposal will be
considered ineligible:
- timely submission: by Thursday, 18thof
April, 2019, 12 noon sharp
- the application shall consist of no more
than 6 pages, excluding the title page and
the identification of the promoters
- the font of the text (Times New Roman,
font size 12) may not be modified
- the application shall be drawn up either in
one or a combination of the national
languages, or else entirely in English
- only Belgian research institutions may
participate in the consortium.
Date, name and signature of the coordinator, as
representative of the consortium
39
Annex 3 Send this form in digital form (Word and pdf, and Excel for annexes 7 and 8) to:
CONFIDENTIAL
FULL THEMATIC PROPOSAL
(RT PROJECT 2nd step) MAX. 30 PAGES (excluding title page and identification of the consortium, but including
the budgetary tables)
[TITLE OF THE TOPIC]
[ACRONYM OF THE TOPIC]
[Title of the project proposal]
Total budget required for the research: € …….
Requested research grant and % of the overall budget: € …….
…… %
In which case: origin of the co-funding:
Proposed start date: …/…/………
Proposed duration of the project: ……. months
40
1. IDENTIFICATION OF THE CONSORTIUM
1.1 IDENTIFICATION OF THE COORDINATOR
NB : maximum one coordinator Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
1.2 IDENTIFICATION OF PROMOTER 2 (optional)
NB: maximum one promoter per research group Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
1.3 IDENTIFICATION OF PROMOTER 3 (optional)
NB: maximum one promoter per research group Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
1.4 IDENTIFICATION OF PROMOTER 4 (optional)
NB: maximum one promoter per research group
Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
41
1.5 IDENTIFICATION OF PROMOTER 5 (optional)
NB: maximum one promoter per research group Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
Box for completion by the Contractual Research Unit
Expert panel
Title
Name
Affiliation
42
2. GENERAL INFORMATION
2.1 Title of the project in English and Dutch or English and French + acronym
2.2 Research questions to which the candidate shall provide an answer in this study, in
English and Dutch or English and French (about 20 lines each)
2.3 Executive summary of the project (about 20 lines)
2.4 Motivation for submitting the project proposal under this topic (about 15 lines)
When stating the research objectives, the applicability of the results for the federal authorities
(direct or indirect; short, medium or long term) must be explained.
2.5 Context: scientific specificity and setting in relation to existing research (about 2.5
pages)
• How is the current project proposal scientifically and technically innovative? Has other
research in relation to the proposed subject already yielded convincing elements that can
be used as a starting point for this project? Which data and preliminary knowledge are
required for this study and are these available or accessible? A bibliography may be
appended.
• What are the achievements of the applicants and/or the researchers in this field? Have you
already conducted research in this field or are you currently conducting research? If yes,
please list the project title(s), the start and end dates of your research and identify the
institution that provided a grant for the research.
• The proposed specific approach to the problem must be justified.
2.6 Use of the expected research results (about 5 lines)
How do you intend to use the results?
- as an intermediary stage for complementary research activities
- for the development, realisation, or dissemination of a procedure or a service
- for the dissemination of new knowledge through scientific publications
2.7 Risks (about 15 lines)
What are the inherent obstacles and/or risks to the proposed project that may compromise
the chances of achieving the objectives within the term you propose? Which solutions do
you propose?
2.8 Proposal for a steering committee (minimum 8 persons, listing affiliation and e-mail
address)
Title – Name – First name Organisation E-mail
43
2.9 Name and identification of the persons who must sign the contract if the project is
eligible for a research grant
Institution Name Position
[NAME]
… ...
[NAME]
… ...
[NAME]
… ...
[NAME]
… ...
[NAME]
… ...
[NAME]
… ...
[NAME]
… ...
44
3. SPECIFIC INFORMATION
3.1 Scientific and operational methodology of the proposed research (about 15 pages)
• This section constitutes the core of the project proposal. It must contain a clear description
of the research activities as planned for the total duration of the project.
• Important elements in the description of the various subtasks of the research programme
are:
- an overview of the proposed research, subdivided into work packages and (sub)tasks,
including an indication of the estimated budget for every work package;
- the proposed methods and technologies with their respective (dis)advantages,
limitations, risks and alternatives,…
- the milestones to be achieved, linked to possible reorientations in the project where
applicable;
- the time frame and evolution over time based on the following chronogram, including
milestones and deliverables:
Year 1 Year 2 Year 3 Year 4 Total
budget
per WP* Code t1 t2 t3 t4 t1 t2 t3 t4 t1 t2 t3 t4 t1 t2 t3 t4
WP1
T1.1.
T1.2.
…
WP2
T2.1.
T2.2.
T2.3.
WP3
…
t: trimester
* total budget per work package: staffing + operational + general costs
45
3.2 Structure and organisation of the research (about 2 pages)
• Indicate the distribution of the various tasks among the consortium partners using the
following table:
Code Task description Contracting
institution(s)
Required
personnel
(qualifications)
P-M
WP1
T1.1.
T1.2.
….
WP2
T2.1.
T2.2.
T2.3.
…
WP: work package
T: task
P-M: person-months
• Please also state whether you are working with foreign partners or participating in
networks, insofar as this is relevant to this project proposal.
• Also indicate whether you are planning a cooperation or whether complementarity exists
with research groups that do not request a financial contribution from the FPS Health for
this project but receive research grants from other bodies to conduct their own research.
• Indicate whether you submitted your project (or sub-project) to another body than the FPS
Health.
3.3 Own publications in peer-reviewed international journals in this field of research in the
past five years
46
4. BUDGETARY INFORMATION
Please refer to the important information in Annex 6
4.1 Budgetary overview table
Please insert the table which you can find in annex 7 on the website
(www.health.belgium.be/contractualresearch) under “open calls” here and submit the table
separately as well as an Excel sheet.
4.2 Detailed budget proposal
Please draft the detailed budget proposal using the Excel sheet provided in annex 8, which
can be downloaded from the website (www.health.belgium.be/contractualresearch) under
“open calls”. The budget proposal is to be inserted here and submitted separately as an Excel
sheet.
5. BIBLIOGRAPHY
NB : have the conditions below been
respected?
If not, your proposal will be
considered ineligible:
- timely submission: by Friday, 27th of
September, 2019, 12 noon sharp
- the application shall consist of no more
than 30 pages, excluding the title page and
the identification of the promoters, but
including the budgetary tables
- the font of the text (Times New Roman,
font size 12) may not be modified
- the application shall be drawn up either in
one or a combination of the national
languages, or else entirely in English
- only Belgian research institutions may
participate in the consortium.
Date, name and signature of the coordinator, as
representative of the consortium
47
Annex 4
Send this form in digital form (Word and pdf) to:
CONFIDENTIAL
RF PRE-PROPOSAL
(RF PROJECT 1st STEP)
MAX. 6 PAGES (excluding the title page and identification of the consortium)
1. IDENTIFICATION OF THE PROJECT PROPOSAL
Project title (max. 3 lines) + proposal for an acronym
Most important field of activity to which
this project proposal relates (only tick
one field please)
Additional field(s) of activity to which this
project proposal relates
Food safety
Animal health
Plant health
Food safety
Animal health
Plant health
2. IDENTIFICATION OF THE COORDINATOR Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
Will this research be conducted in a consortium (with the partners included in the
budget)? If yes, please list the other promoters here (name, affiliation and e-mail
address)
48
3. REPETITION OF THE PROJECT TITLE + PROPOSAL FOR AN ACRONYM
4. CONTEXT
4.1 Description of the context of this project proposal (about 20 lines)
What is the problem? What causes it?
4.2 To which extent are you involved in the general problem on which this project proposal
is based? (about 20 lines)
What is your expertise in this field? Have you already conducted research in this field or are
you currently conducting research? If yes, please list the project title(s), the start and end
dates of your research and identify the institution that provided a grant for the research.
Are you working with other institutions in Belgium and/or abroad? If yes, are you a member
of a network?
5. RESEARCH QUESTIONS (about 20 lines)
To which research question(s) must the proposed study provide an answer to contribute to a
solution to the problem listed under 4.1?
6. IMPACT OF THE RESEARCH SUBJECT
6.1 Incidence (about 5 lines)
Does this research proposal relate to a quantitatively important problem, which occurs
frequently or affects a large number of individuals?
6.2 Seriousness of the problem (about 5 lines)
Does the research subject present a serious risk or could it present a serious risk for food
safety or the health policy of animals and plants in terms of
- their health, quality of life?
- the effectiveness or the quality of actions (cures, recommendations, drugs or measures)?
- social or ethical questions?
6.3 Financial impact (about 5 lines)
Does the subject potentially have an influence on
- the current impact of the problem (including on sustainable development)?
- the resources that are used for the problem and their effectiveness?
6.4 Does the research subject correspond with a concern of society or the population?
(about 5 lines)
6.5 Is the implementation of the results yielded by this research acceptable for the sector
involved? In other words, does the research fulfil the sector’s expectations? (about 5
lines)
49
6.6 Possibilities for improving the situation (about 5 lines)
Can the proposed research provide a solution to the described problem? If yes, for which of
the levels listed under 6.2.-6.3 would this be the case and is this a short, medium or long-
term solution?
7. RELEVANCE FOR THE AUTHORITIES’ DECISIONS (about 10 lines)
How can this research potentially support the decisions that the Authorities must take? What
would be the risk if the situation remains “as is”?
Who is involved in the execution of this study and who are the stakeholders for the
implementation of the research results?
8. DESCRIPTION OF THE PROJECT PROPOSAL
If necessary, brief references may be included in the text (e.g. Johnson et al., 2012).
8.1 Methodology (about 40 lines)
Describe the methodology you will use for this research. Was this methodology previously
applied, by the applicants, by other Belgian researchers or by foreign researchers?
8.2 Available scientific proof in relation to the proposed research (about 20 lines)
Has other research in relation to the proposed subject already yielded convincing elements
(“proof”) which can be used as a starting point for this project? List this research in order of
importance. In what respect is the current project proposal innovative?
8.3 Required data (about 10 lines)
Are there any data and/or preliminary knowledge available, which is required for this study?
If yes, are these data available in accessible databases? If no data are available yet, then
please explain how these data can be obtained.
8.4 Risks (about 10 lines)
What are the inherent obstacles and/or risks to the proposed project that may compromise its
chances of success? Which solutions do you propose?
9. USE OF THE RESEARCH RESULTS (about 10 lines)
How do you intend to use the results?
- as an intermediary stage for complementary research activities
- for the development, realisation, or dissemination of a procedure or a service
- for the dissemination of new knowledge through scientific publications
10. BUDGETARY INFORMATION
Please refer to the important information in Annex 6.
For your information: annexes 7 and 8 are only to be submitted in the second step of the
selection procedure.
10.1 Total duration of the proposed project
(min. 12 months – max. 48 months) …… months
10.2 Total budget for this project proposal € …….
10.3 Requested research grant € …….
50
The requested grant – 1 figure only – can be equal to the overall budget or to a percentage
of this budget. In the latter case, please state the origin of your external financial
contribution.
10.4 In which case: percentage of co-funding …… %
10.5 In which case: origin of the co-funding …….
10.6 Persons included in the budget, their qualification (e.g. PhD, PhD student, engineer,
Ma., pharmacist, lab technician, et al.), affiliation and time spent on the research in
person-months (P-M)
Qualification Name (if known) Affiliation P-M
NB : have the conditions below been
respected?
If not, your proposal will be
considered ineligible:
- timely submission: by Thursday, 18th of
April, 2019, 12 noon sharp
- the application shall consist of no more
than 6 pages, excluding the title page and
the identification of the promoters
- the font of the text (Times New Roman,
font size 12) may not be modified
- the application shall be drawn up either in
one or a combination of the national
languages, or else entirely in English
- only Belgian research institutions may
participate in the consortium.
Date, name and signature of the coordinator, as
representative of the consortium
51
Annex 5 Send this form in digital form (Word and pdf, and Excel for annexes 7 and 8) to:
CONFIDENTIAL
RF FULL PROPOSAL
(RF PROJECT 2nd STEP) MAX. 30 PAGES (excluding title page and identification of the consortium, but including
the budgetary tables)
[ACRONYM]
[Title of the project proposal]
Total budget required for the research: € …….
Requested research grant and % of the overall budget: € …….
…… %
In which case: origin of the co-funding:
Proposed start date: …/…/………
Proposed duration of the project: ……. months
52
1. IDENTIFICATION OF THE CONSORTIUM
1.1 IDENTIFICATION OF THE COORDINATOR
NB : maximum one coordinator Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
1.2 IDENTIFICATION OF PROMOTER 2 (optional)
NB: maximum one promoter per research group Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
1.3 IDENTIFICATION OF PROMOTER 3 (optional)
NB: maximum one promoter per research group
Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
1.4 IDENTIFICATION OF PROMOTER 4 (optional)
NB: maximum one promoter per research group
Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
53
1.5 IDENTIFICATION OF PROMOTER 5 (optional)
NB: maximum one promoter per research group
Name
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
Box for completion by the Contractual Research Unit
Expert panel
Title
Name
Affiliation
54
2. GENERAL INFORMATION
2.1 Title of the project in English and Dutch or English and French + acronym
2.2 Research questions to which the candidate shall provide an answer in this study, in
English and Dutch or English and French (about 20 lines each)
2.3 Executive summary of the project (about 20 lines)
2.4 Context: scientific specificity and setting in relation to existing research (about 2.5
pages)
• How is the current project proposal scientifically and technically innovative? Has other
research in relation to the proposed subject already yielded convincing elements (“proof”)
that can be used as a starting point for this project? Which data and preliminary knowledge
are required for this study and are these available or accessible? A bibliography may be
appended.
• What are the achievements of the applicants and/or the researchers in this field? Have you
already conducted research in this field or are you currently conducting research? If yes,
please list the project title(s), the start and end dates of your research and identify the
institution that provided a grant for the research.
• The proposed specific approach to the problem must be justified.
2.5 Use of the expected research results (about 5 lines)
• How do you intend to use the results?
- as an intermediary stage for complementary research activities
- for the development, realisation, or dissemination of a procedure or a service
- for the dissemination of new knowledge through scientific publications
2.6 Risks (about 15 lines)
• What are the inherent obstacles and/or risks to the proposed project that may compromise
the chances of achieving the objectives within the term you propose? Which solutions do
you propose?
2.7 Proposal for a steering committee (minimum 8 persons, listing affiliation and e-mail
address)
Title – Name – First name Organisation E-mail
55
2.8 Name and identification of the persons who must sign the contract if the project is
eligible for a research grant
Institution Name Position
[NAME]
… ...
[NAME]
… ...
[NAME]
… ...
[NAME]
… ...
[NAME]
… ...
[NAME]
… ...
[NAME]
… ...
56
3. SPECIFIC INFORMATION
3.1 Scientific and operational methodology of the proposed research (about 15 pages)
• This section constitutes the core of the project proposal. It must contain a clear description
of the research activities as planned by you for the total duration of the proposed project.
• Important elements in the description of the various subtasks of the research programme
are:
- an overview of the proposed research, subdivided into work packages and (sub)tasks,
including an indication of the estimated budget needed for every work package;
- the proposed methods and technologies with their respective (dis)advantages,
limitations, risks and alternatives…
- the milestones to be achieved, linked to possible reorientations in the project where
applicable;
- the time frame and evolution over time based on the following chronogram, including
milestones and deliverables:
Year 1 Year 2 Year 3 Year 4 Total
budget
per WP* Code t1 t2 t3 t4 t1 t2 t3 t4 t1 t2 t3 t4 t1 t2 t3 t4
WP1
T1.1.
T1.2.
…
WP2
T2.1.
T2.2.
T2.3.
WP3
…
t: trimester
* total budget per work package: staffing + operational + general costs
57
3.2 Structure and organisation of the research (about 2 pages)
• Indicate the distribution of the various tasks among the consortium partners using the
following table:
Code Task description Contracting
institution(s)
Required
personnel
(qualifications)
P-M
WP1
T1.1.
T1.2.
….
WP2
T2.1.
T2.2.
T2.3.
…
WP: work package
T: task
P-M: person-months
• Please also state whether you are working with foreign partners or participating in
networks, insofar as this is relevant to this project proposal.
• Also indicate whether you are planning a cooperation or whether complementarity exists
with research groups that do not request a financial contribution from the FPS Health for
this project but receive research grants from other bodies to conduct their own research.
• Indicate whether you have also submitted your project (or sub-project) to another body
than the FPS Health.
3.3 Own publications in peer-reviewed international journals in this field of research in the
past five years
58
4. BUDGETARY INFORMATION
Please refer to the important information in Annex 6
4.1 Budgetary overview table
Please insert the table which you can find in annex 7 on the website
(www.health.belgium.be/contractualresearch) under “open calls” here and submit the table
separately as well as an Excel sheet.
4.2 Detailed budget proposal
Please draft the detailed budget proposal using the Excel sheet provided in annex 8, which can
be downloaded from the website (www.health.belgium.be/contractualresearch) under “open
calls”. The budget proposal is to be inserted here and submitted separately as an Excel sheet.
5. BIBLIOGRAPHY
NB : have the conditions below been
respected?
If not, your proposal will be
considered ineligible:
- timely submission: by Friday, 27th of
September, 2019, 12 noon sharp
- the application shall consist of no more
than 30 pages, excluding the title page and
the identification of the promoters, but
including the budgetary tables
- the font of the text (Times New Roman,
font size 12) may not be modified
- the application shall be drawn up either in
one or a combination of the national
languages, or else entirely in English.
Date, name and signature of the coordinator, as
representative of the consortium
59
Annex 6
Important information about the budget
1. Generalities • We firmly recommend you involve your accountancy service when drawing up your
budget.
• Apart from the information in this annex, the information which is mentioned in chapter 5
of the manual of Contractual Research can be useful (cf. website
www.health.belgium.be/recherchecontractuelle under “Project follow-up”).
• The expenses covered by this grant must be made in accordance with the statutory and
regulatory provisions governing public procurement (see
https://www.publicprocurement.be/fr/publicprocurementbe-english-0). This applies in
particular for purchases and subcontracting.
2. Allocated grant • The requested grant and its distribution must correspond with the real cost in relation to
the duration, the nature, the required equipment and expertise of the research needed to
achieve the objectives pursued.
• For RT proposals, the research grant is capped on the amount indicated in the topic
description (Annex 1).
• The requested grant must be rounded off to an amount in k€; if not the amount will be
automatically rounded off by our services (e.g. a requested grant of € 215,321 will be
rounded down to € 215,000).
• When drawing up your budget, you must bear in mind that all non-lump sum expenses,
those at the expense of the FPS as well as those from own contributions, will be checked
against the vouchers to be provided.
• Maximum share of the allocated grants: 100% (royal decree of November18th, 2015).
• In principle, any financial contribution is acceptable as an own contribution as long as it
does not give rise to a conflict of interests and as long as it is not granted by the federal
authorities. The restrictions in paragraphs 3, 4 and 5 below must also be taken into account.
3. Staffing costs • The staffing costs for the coordinator and the promoters may not be included in the project
budget, nor at the expense of the FPS, nor as an own contribution.
• All staffing costs related to the project’s execution, excluding the staffing costs for the
coordinator and the promoters, must be indicated in this section. Exceptions to this rule
include labour costs included in the budget for subcontracted work.
If your project is selected for a grant, staffing expenses declared in the financial reporting
that are included in the operational costs (e.g. analysis costs) will be rejected.
• In order for doctoral grants to be considered as an own contribution, these must be funded
with the research institution’s own resources or must be funded by another body than the
federal government.
• The staffing costs are calculated based on the pay scales of the institutions where the staff
is employed.
• The detailed budget is to show the pay scale, seniority and time spent on the project (in
person-months) per calendar year. If the names of the staff members are known, they must
be stated.
• The staffing costs are split in gross wages on the one hand and other costs on the other
60
hand. The costs for a research fellow (PhD student), who per definition is not considered
an employee, are to be presented as a whole in a single article.
3.1 Staffing costs which can be paid with the research grant
Research grants can be used to cover the following staffing costs:
- indexed gross monthly salary or grant (including and if applicable NSSO employee
contribution, withholding tax and if applicable, the employee contribution for meal
vouchers);
- employer contribution NSSO, holiday pay and year-end bonus;
- other wage costs, if applicable, including:
o statutory insurance (e.g. for occupational accidents);
o statutory compensation or benefit as a supplement to the employee’s salary (e.g.
household or residence allowances if applicable, a premium for bilingual
employees, benefits in kind set out in a CLA…);
o statutory interventions in the cost for commuting from home to work based on the
price of a public transport pass (for train passes: 2nd class only);
o bike allowances as stated on the employee’s pay slip or the individual annual
statements in accordance with the Federal Authorities’ statutory tariff;
o if applicable, the flat-rate contribution for the work of prevention advisors of the
External Services for Prevention and Protection at Work (royal decree of March
27th, 1998, royal decree of May 28th, 2003 - health monitoring).
3.2 Staffing costs which cannot be covered with the research grant
The following costs (non-limitative list) cannot be covered with a research grant unless they are
statutory benefits1:
- extra-legal insurance costs (hospitalisation, group insurance plan …);
- administration costs of the social secretariat;
- extra-legal benefits (overtime, employer contribution for meal vouchers, company car,
benefits in kind, supplementary family allowance, child-care allowance, representation costs,
work clothes, extra-legal pension, extra-legal premiums);
- attendance fees.
1 For example legislation for staff working in public administrations, as set out in a royal decree or decree published
in the Belgian Official Gazette, a CLA which is declared to be universally applicable following its publication in the
Belgian Official Gazette
61
4. Operational costs
Operational costs are project-related costs that are incurred with a view to the purchase and/or the
operational use of goods or services, and costs that are directly related to the project activities.
The operational costs will be split into flat-rate standard operational costs and specific operational
costs.
4.1 Standard operational costs
The standard operational costs are flat-rate costs and include usual expenses related to the project’s
execution such as:
- ordinary supplies and products for the lab (e.g. glassware, pipettes, detergents), the
workplace (e.g. recipients, carts, commonly used tools) and the office (e.g. perforators, ink
cartridges)
- documentation (e.g. purchase of books, fees for ordering scientific articles)
- travel and accommodation in Belgium and abroad
- the use of computers
- frequently used software
- …
No own contributions can be budgeted under the standard operational costs.
The amount of these operational costs is a lump sum that is established based on a percentage of
the staffing costs funded by the FPS Health. This percentage may not exceed 15% of the funded
staffing costs for the coordinator and 10% of these costs for the other promoters.
4.2 Specific operational costs
Specific operational costs include all the special operational costs that are directly related to the
project’s execution. Specific operational costs include:
- usage costs for equipment (includes specific IT equipment needed for the use of this
equipment);
- maintenance costs for equipment;
- costs for analyses ;
- subcontracted work.
62
a) The cost for the usage of equipment acquired through purchase or hire purchase are calculated
as follows:
𝑝𝑢𝑟𝑐ℎ𝑎𝑠𝑒 𝑝𝑟𝑖𝑐𝑒
𝑎𝑚𝑜𝑟𝑡𝑖𝑠𝑎𝑡𝑖𝑜𝑛 𝑝𝑒𝑟𝑖𝑜𝑑 × 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑜𝑛𝑡ℎ𝑠 𝑡ℎ𝑒 𝑑𝑒𝑣𝑖𝑐𝑒 𝑖𝑠 𝑢𝑠𝑒𝑑 𝑖𝑛 𝑡ℎ𝑒 𝑝𝑟𝑜𝑗𝑒𝑐𝑡 × % 𝑜𝑓 𝑢𝑠𝑒 𝑓𝑜𝑟 𝑡ℎ𝑒 𝑝𝑟𝑜𝑗𝑒𝑐𝑡
The amortisation period (economic lifespan) is the period indicated in your accounts. In general,
this period is 5 to 10 years for scientific equipment.
An example:
- you have a device that costs 30,000 euros at purchase
- The device is written off over a period of 60 months
- although the duration of the project is 36 months, the device will only be used for 10 months
of the project
- during these 10 months the device will also be used for other projects. The average usage
percentage for the project during this period is 20%
The usage cost is then calculated as follows:
𝑢𝑠𝑎𝑔𝑒 𝑐𝑜𝑠𝑡 = € 30,000
60 𝑚𝑜𝑛𝑡ℎ𝑠 × 10 𝑚𝑜𝑛𝑡ℎ𝑠 × 0.2 = € 1,000
b) When renting equipment the usage cost is calculated as follows:
𝑚𝑜𝑛𝑡ℎ𝑙𝑦 𝑟𝑒𝑛𝑡 × 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑜𝑛𝑡ℎ𝑠 𝑡ℎ𝑒 𝑑𝑒𝑣𝑖𝑐𝑒 𝑖𝑠 𝑢𝑠𝑒𝑑 𝑖𝑛 𝑡ℎ𝑒 𝑝𝑟𝑜𝑗𝑒𝑐𝑡 × % 𝑜𝑓 𝑢𝑠𝑒 𝑓𝑜𝑟 𝑡ℎ𝑒 𝑝𝑟𝑜𝑗𝑒𝑐𝑡
If the device in the above example costs € 600 a month to rent, the usage cost is calculated as
follows:
𝑢𝑠𝑎𝑔𝑒 𝑐𝑜𝑠𝑡 = € 600 × 10 𝑚𝑜𝑛𝑡ℎ𝑠 × 0.2 = € 1,200
c) The cost of subcontracting work comprises the cost that a promoter pays to a third party to carry
out tasks or to provide services, for which specific scientific or technical skills are required and
which are not part of the consortium’s ordinary activities.
Subcontracting is only admissible if
- it provides demonstrable added value for the project;
- the subcontractor does not take over the core activity and only is responsible for part of the
project;
- the cost of subcontracting is no more than 25% of the overall grant to the promoter;
- detailed budgetary information is provided;
- the budget for subcontracting the work is not provided as a lump sum (as a % of the total
budget).
63
In case no or insufficient standard operational costs can be reported for one or more partners due
to limited or lacking staffing costs funded by the FPS Health, costs related to for example inland
or foreign duty travel may be introduced as specific operational costs, provided that this can be
well motivated.
5. General costs
The general costs include the costs for administration, phone, postage, the maintenance of the
premises, heating, lighting, electricity, rent or insurance.
No own contributions may be budgeted under general costs.
These general costs must be budgeted as a lump sum based on maximum 10% of the staffing costs
funded by the FPS Health.
64
Annex 7
Table to be used for the budgetary overview (to be inserted in the RT and RF full proposal in step 2)
Type of cost
[Identification
Coordinator]
[Identification
Promoter 2]
[Identification
Promoter 3]
[Identification
Promoter 4]
Total per
item
Staffing
Operational
General
Total per
partner
Own
contribution
% own
contribution
FPS Grant
% FPS Grant
65
Annex 8
Template to be used for the detailed budgetary information (to be inserted in the RT and RF full proposal in step 2)
All promoters of the consortium must be listed for each category of expenses, even if for some
of them no expenses are foreseen in one or more of the categories.
Indicate own contributions with *
4.1. Staffing costs 0
year seniority
in years number of
person-months budget
in euros
4.1.1. Lab of X (Affiliation) 0
4.1.1.1. N. 0
Fellow 2020 [0] [3] …
2021 [1] [12] …
….
4.1.1.2. N. 0
Pay scale 2020 [4] [1] …
2021 [5] [9] …
… …. …
4.1.1.3. - double holiday pay …
- employer contributions (social security, insurance)
- year-end bonus
- other
4.1.2. Lab of Y (Affiliation) 0
4.1.2.1. N. 0
Pay scale 2020 [4] [3] …
2021 [5] [12] …
… …. … …
4.1.2.2. - double holiday pay …
- employer contributions (social security, insurance)
- year-end bonus
- other
66
4.1.2.3. N. 0
Pay scale 2020 [4] [1] …
2021 [5] [9] …
… … … …
4.1.2.4. - double holiday pay … …
- employer contributions (social security, insurance)
- year-end bonus
- other
4.2. Operational costs 0
4.2.1. Lab of X (Affiliation) 0
4.2.1.1. Standard operational costs (flat-
rate) …
4.2.1.2. Specific operational costs 0
4.2.1.2.1. e.g. Reagents for PCR …
4.2.1.2.2. … …
4.2.1.2.3. … …
4.2.1.2.4. … …
…
4.2.2. Lab of Y (Affiliation) 0
4.2.2.1. Standard operational costs (flat-
rate) …
4.2.2.2. Specific operational costs 0
4.2.2.2.1. e.g. Purchase of plants …
4.2.2.2.2. Cell cultures …
4.2.2.2.3. … …
…
4.3. General costs 0
4.3.1. Lab of X (Affiliation) 0
4.3.1.1. Overheads …
4.3.2. Lab of Y (Affiliation) 0
4.3.2.1. Overheads …
TOTAL 0
67
Annex 9
Research topics (RI projects): plant health – Euphresco
Topic code Topic title
2019-F-310 PhyLib III
2019-C-315 Efficacy of Anaerobic Digestion as a means of destruction for infected plant
material
2019-E-328 Next generation sequencing in bacterial diagnostics: WGS & meta-barcording
2019-A-330 Detecting virus-carrying Xiphinema spp. as an alternative to Xiphinema
identification up to species level in trade
2019-A-331 Remote sensing in plant health: expanding the scene (PLANTRESENS)
68
2019-F-310 PhyLib III
Short description
The number of psyllid species known to harbor Liberibacter solanaceum (Lso) is increasing. It is
necessary to understand the ability of these psyllids to vector Lso and the potential risks they pose
to crop plants. This will require the establishment of Lso +ve and –ve psyllid colonies for lab-
based transmission studies, plant choice experiments, host plant interaction studies and psyllid
behaviour studies. This will be complemented by genome analysis of a range of newly identified
Lso haplotypes via genome sequencing, MLST and gene expression approaches. This will enable
comparison of: different haplotypes, geographical differences between the same haplotypes; genes
responsible for pathogenicity and microbe-plant/ microbe-psyllid interactions. Psyllid diversity
across Europe will be monitored via field surveys and suction trap sampling, along with the
prevalence and distribution of Lso and Phytoplamas and potential weed/over wintering reservoirs
of these microbes.
The project should include :
- characterization of new Lso haplotypes/ Liberibacter spp. from new psyllid hosts
- genome seq / MLST of haplotype U (from multiple locations)
- screening psyllid specimens for Lso (field and suction trap)
- screening psyllid specimens for Phytoplasmas
- screening alternative insect groups for Lso and Phytoplasmas (aphids, hoppers, other
hemiptera)
- set-up colonies of T. urt, T. anthrisci and N. subpunctata
- transmission studies on T. urticae and T. anthrisci, N. subpunctata (host plant, transmission
to carrot and potato)
- plant choice studies on T. urticae and T. anthrisci, N. subpunctata
- overwintering hosts
- EPG on T. anthrisci
Description of the end product
An enhanced understanding of Lso populations and their vectors and the risk they pose to crop
health.
Provisional other funders (to be completed in a later stage)
Science and Advice for Scottish Agriculture (SASA), UK (contact: Dr. David Kenyon,
Provisional project duration
> 2 years
69
2019-C-315 Efficacy of Anaerobic Digestion as a means of destruction for infected plant
material
Short description
Investigate the efficacy of Anaerobic Digestion as a means of destruction for infected plant
material, rather than landfill or incineration, such as required following a diagnosis of Xylella,
Xanthomonas, and other quarantine pathogens and pests.
Determine culture viability following processing, for example through molecular analysis.
Description of the end product
Methodology to test output for pathogen viability; protocol as means of processing of infected
planting material.
Provisional other funders (to be completed in a later stage)
• Department for Environment, Food and Rural Affairs, UK (Contact: Ms Laura Pinney,
Provisional project duration
1 - 2 years
70
2019-E-328 Next generation sequencing in bacterial diagnostics: WGS & meta-barcording
Short description
Next generation sequencing (NGS) in its various forms has provided significant benefits to the
viral diagnostics. In bacteriology, it is used to a limited extent. The aim of the project would be to
facilitate exchange of knowledge and experience with NGS in bacteriology and to identify critical
points and potential benefits. The exchange would take place in the form of symposia, exchange
of protocols and/or laboratory visits. Two broad areas will be examined, whole genome sequencing
(WGS) and meta-barcoding.
WGS and tools of comparative genomics allow characterization of completely unknown
pathogens, resolving taxonomy issues, informed selection of novel targets for detection tests, more
efficient outbreak analysis, identification of novel relevant characteristics (effectors, virulence
factors, antibiotic resistance). Meta-barcoding is a rapid method of biodiversity assessment that
combines two technologies: DNA-based identification and high-throughput DNA sequencing. It
is particularly useful when it is preferable to use a combination of a more generic detection method
with more or less targeted approach.
Capacity of laboratories to perform WGS and/or meta-barcoding analysis will be mapped from
both infrastructure and knowledge requirements and the critical challenges for its adoption will be
identified. This would allow for a coordinated further activity of the reference laboratories in the
transfer of WGS and comparative genomics into routine use.
Description of the end product
Identification of NGS potential and plans for further collaboration (white paper or publication)
Provisional other funders (to be completed in a later stage)
• Ministry of Agriculture Foresty and Food, Slovenia (Contact: Ms Erika Oresek,
Provisional project duration
> 2 years
71
2019-A-330 Detecting virus-carrying Xiphinema spp. as an alternative to Xiphinema
identification up to species level in trade
Short description
Nematodes of the genus Xiphinema (dagger nematodes) are migratory root ectoparasites with a
broad host range. There are more than 260 species, of which approximately 50 belong to the
Xiphinema americanum group (X. americanum sensu lato). This group has a quarantine status as
some of the species can transmit certain nepoviruses. The identification up to species level is quite
difficult based on morphological and morphometric data, and most of the time impossible due to
lack of specimen or appropriate stadia. There is not enough molecular information available of all
species to develop reliable tools such as PCR or barcoding. However, the main issue is that some
specimen are potential carriers of viruses. Therefore, it has been suggested that only those species
that have been shown to carry viruses are considered quarantine organisms, although their
identification is very difficult. Focusing on a direct detection of these viruses in the nematodes
could be an alternative to correctly identifying these Xiphinema species that are able to transmit
viruses. This way, only specimen of the X. americanum group that are carrying viruses can be
considered as a Plant Health risk, and consignments carrying Xiphinema spp. free of viruses could
enter trade.
In this project, reliable techniques to detect viruses in Xiphinema nematodes will be developed and
validated, with an emphasis on sensitivity and specificity. The tool could later be applied to other
nematode genera transmitting viruses.
Description of the end product
A validated technique for detection of viruses in Xiphinema nematodes that are of quarantine
concern.
Provisional other funders (to be completed in a later stage)
• Institute for Agricultural and Fisheries Research, Belgium (Contact: Mr Kris De Jonghe,
Provisional project duration
1 - 2 years
72
2019-A-331 Remote sensing in plant health: expanding the scene (PLANTRESENS)
Short description
In recent years, great progress has been made in the use of remote sensing in various domains,
including plant health. The state-of-the art has been presented during the scientific colloquium
“perspectives on the use of remote sensing in plant health” co-organised by EPPO and Euphresco
in September 2018.
Building on today’s knowledge, the scientific community as well as policy makers acknowledged
that further research and enlarged transnational collaboration is needed to bridge the gap between
research and application of remote sensing in practice.
The Euphresco project PHeRS, presented at the Colloquium, has shown that remote sensing has a
large potential as a tool for official monitoring of regulated harmful organisms. In the PHeRS
report, recommendations for further research were identified in view of overcoming current
limitations for plant health application. For example, research is needed to identify wavelength
packages for detecting specific biotic and abiotic stresses, to develop near-ground or other sensors
targeting harmful organisms of phytosanitary concern, and to advance algorithms and software in
a way that Remote Sensing can easily be used by inspectors in the field.
It is encouraged to expand the applicability of the technique towards different fields in plant health
(forestry, field crops, fruit, potatoes, ….) and to target a wide range of harmful organisms.
Description of the end product
Advances in remote sensing for official monitoring, practical applications
Provisional other funders (to be completed in a later stage)
not identified yet
Provisional project duration
3 years
73
Annex 10
Submit this form electronically (Word and
.pdf) to:
CONFIDENTIAL
Contractual Research Euphresco call
EXPRESSION OF INTEREST
(RI PROJECT 1st stage)
MAX. 4 PAGES
(excluding the title page and identification of the consortium)
1. TITLE OF THE PROJECT PROPOSAL
[CODE AND TITLE OF THE TRANSNATIONAL TOPIC]
[Title of the Belgian consortium’s project proposal]
[proposed acronym]
2. IDENTIFICATION OF THE COORDINATOR
Surname
First name
Title or position
Institute and department
Address for correspondence
Phone
Mobile phone
Will this research be conducted in a consortium (with the partners included in the
budget)? If yes, please list the other promoters here (name, affiliation and e-mail
address)
74
3. EXPRESSION OF INTEREST – PROPOSAL DETAILS
3.1 Description of the context of this project proposal, taking into account the topic
description (about 20 lines)
3.2 Proposed transnational project outline (about 15 lines)
Please outline the transnational project approach you would propose to the future transnational
research consortium in order to reach the objectives of the topic. The specific Belgian tasks are
to be described under 3.3.
3.3 Research capacity (about 30 lines)
Please describe your own research capacity within the project. Which part of the proposed
transnational project programme could you address? Which research questions / objectives could
you address? Consequently, which work packages / tasks do you propose to address? Which
infrastructure and staff (qualification, proposed number of person-months) can you deploy?
3.4 Expertise and experience (about 30 lines)
Please describe the relevant expertise and experience that you have in the topic area.
Please list up to 5 key relevant publications per partner.
4. BUDGETARY INFORMATION
Please refer to the important information in Annex 6.
4.1 Total duration of the proposed project … months
4.2 Total budget for this project proposal € …….
4.3 Requested research grant € …….
4.4 In which case: percentage of co-funding …… %
In which case: origin of the co-funding
NB : have the conditions listed below been
respected? If not, your Expression of
Interest will be considered ineligible:
- timely submission: by Tuesday April 18th, 2019,
12 noon sharp
- the application shall consist of no more than 4
pages, excluding the title page and the
identification of the promoters
- the font of the text (Times New Roman, font size
12) may not be modified
- the application is drawn up entirely in English
- only Belgian research institutes may participate
in the consortium proposed by this Expression of
Interest.
Date, name and signature of the coordinator,
on behalf of the consortium
Copyright:
Melissa Schalke – fotolia.fr
Larisa Lofitskaya – fotolia.fr
OlegDoroshin
Contact:
Dominique Vandekerchove
DG Animals, Plants and Food – Unit Contractual Research
Tel: 02 524 90 91
Mail: [email protected]
www.health.belgium.be/contractualresearch
Resp. Ed.: Tom Auwers, Victor Horta square, 40/10, 1060 Brussels